
 
written. Final diagnosis by medical specialists was 
as follows: 41 were diagnosed with Alzheimer’s, 2 
with vascular dementia and 5 with other diseases. 
6 DISCUSSIONS 
Community-based screening is a useful way to 
detect persons with dementia in their early stages. 
Several different tests were developed for the 
purpose of screening dementia. The Mini-Mental 
State Examination (MMSE) and the Hasegawa 
dementia scale, which are basically based on face-
to-face interviews, are widely used to differentiate 
between normal aged people and cases of dementia 
in Japan. However, these tests were originally 
designed to diagnose dementia, and are not suitable 
for community-based settings because they take too 
long and are too cumbersome to administer(David 
and Jeffrey, 1999). A useful screening battery for 
dementia needs to be brief, simple and accurate. In 
this study, the primary screening program revealed 
that overall sensitivity and specificity for screening 
dementia was 96% and 86%, respectively, which 
were equivalent to other studies (Mendiondo et al., 
2003), (Shulman, 2000), (Solomon et al., 1998). 
When we develop a computer system whose main 
target users are elderly persons, the system should be 
easy to operate even by a person with slight mentally 
debilitating disorders or without any type of 
experience with a computer. Adopting a touch panel 
display as an input device with the help of text 
prompts and audio instructions could present an easy 
user-computer interface and almost all of the 
subjects could understand how to interact with the 
system and completed the tasks by themselves.  In 
the actual screening procedure, we detected 55 
persons with MCI and 74 persons as suspected of 
suffering with dementia out of 998 elderly residents. 
We believe that this computerized screening system 
is useful for community-based settings and 
contributes toward the early detection of persons 
with dementia. 
REFERENCES 
Buschke H, Kuslansky G, Katz M, et al. Screening for 
dementia with the Memory Impairment Screen. 
Neurology 1999; 52: 231-238. 
Barker WW, Luis C, Harwood D, et al. The effect of a 
memory screening program on the early diagnosis of 
Alzheimer disease. Alzheimer Dis Assoc Disord. 
2005; 19: 1-7. 
Knopman DS. Current treatment of mild cognitive 
impairment and Alzheimer's disease. Curr Neurol 
Neurosci Rep 2006; 6: 365-371. 
Bennett DA, Schneider JA, Arvanitakis Z, et al. 
Neuropathology of older persons without cognitive 
impairment from two community-based studies. 
Neurology 2006; 66: 1837-1844. 
Ganguli M, Rodriguez E, Mulsant B, et al. Detection and 
management of cognitive impairment in primary care: 
The Steel valley Senior survey. J Am Geriatr Soc 
2004; 52: 1668-1675.  
Letz R, Green RC, Woodard JL. Development of a 
computer-based battery designed to screen adults for 
neuropsychological impairment. Neurotoxicol Teratol 
1996; 18(4): 365-370. 
Katho S, Shimogaki H, Onodera A, et al. Development of 
the revised version of Hasegawa’s Dementia Scale, 
Ronen Seishin Igaku Zasshi 1991; 2: 1339-1347. (in 
Japanese) 
Doraiswamy PM, Bieber F, Kaiser L, Krishnan KR, et al. 
The Alzheimer's Disease Assessment Scale: patterns 
and predictors of baseline cognitive performance in 
multicenter Alzheimer's disease trials. Neurology. 
1997;48(6):1511-1517.  
American Psychiatric Association. Diagnostic and 
statistical manual of mental disorders. 3rd ed, revised. 
Washington, DC: American Psychiatric Association; 
1987. 
David RD, Jeffrey LC. Evaluating dementia screening 
tests. Neurology 1999; 52: 224-227. 
Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA. 
Designing a Brief Alzheimer Screen (BAS). J 
Alzheimers Dis 2003; 5: 391-398. 
Shulman KI. Clock-drawing: is it the ideal cognitive 
screening test? Int J Geriatr Psychiatry 2000; 15: 548-
561. 
Solomon PR, Hirschoff A, Kelly B, et al. A 7 minute 
neurocognitive screening battery highly sensitive to 
Alzheimer's disease. Arch Neurol 1998; 55: 349-355. 
HEALTHINF 2009 - International Conference on Health Informatics
404